CS
PRVA icon

Credit Suisse’s Privia Health PRVA Stock Holding History

Credit Suisse’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$12.8M Buy
651,240
+521,743
+403% +$11M 0.01% 812
2023
Q4 		$2.98M Buy
129,497
+761
+0.6% +$17K ﹤0.01% 1651
2023
Q3 		$2.96M Sell
128,736
-17,362
-12% -$441K ﹤0.01% 1589
2023
Q2 		$3.81M Buy
146,098
+41,968
+40% +$1.11M ﹤0.01% 1515
2023
Q1 		$2.88M Buy
104,130
+8,866
+9% +$234K ﹤0.01% 1654
2022
Q4 		$2.16M Buy
95,264
+25,432
+36% +$708K ﹤0.01% 1822
2022
Q3 		$2.38M Buy
69,832
+5,170
+8% +$191K ﹤0.01% 1750
2022
Q2 		$1.88M Buy
64,662
+5,710
+10% +$145K ﹤0.01% 1962
2022
Q1 		$1.58M Buy
58,952
+37,626
+176% +$888K ﹤0.01% 2239
2021
Q4 		$551K Buy
+21,326
New +$532K ﹤0.01% 3744

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse's PRVA Position: Q1 2024 in Review

Credit Suisse increased its Privia Health (PRVA) stake by 403% in Q1 2024, buying an estimated $11M and bringing the position to 651,240 shares worth $12.8M. The position accounts for 0.01% of the portfolio, ranked #812.

Credit Suisse first reported a position in PRVA in Q4 2021 and has held it in 10 quarters since. 234 funds tracked by Wall St. Rank hold PRVA as of Q1 2024.

  • Credit Suisse held 651,240 shares of Privia Health worth $12.8M as of Q1 2024.
  • Credit Suisse bought 521,743 Privia Health shares in Q1 2024, an estimated $11M.
  • Privia Health made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #812 holding.
  • Credit Suisse first reported a position in Privia Health in Q4 2021 and has held it in 10 quarters since.
  • 234 funds tracked by Wall St. Rank held Privia Health as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.